Cyril DI GRANDI
CEO

Avicenna.ai develops AI solutions for emergency radiology, focusing on the automated detection of critical conditions such as intracranial hemorrhage and large vessel occlusion in CT scans. By reducing interpretation time and prioritizing urgent cases, their technology enhances diagnostic accuracy and improves patient outcomes in high-stakes medical environments.
Raised to date
$10.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CEO
Emergency radiology faces challenges in the timely and accurate detection of critical conditions in CT scans, leading to potential delays in diagnosis and treatment. The complexity of interpreting these scans, coupled with increasing workloads, can overwhelm radiologists and impact patient outcomes.
Avicenna.AI develops AI-powered solutions designed to automate the detection of life-threatening conditions in CT scans, enabling faster and more accurate diagnoses. Their suite of tools, including CINA-ICH for intracranial hemorrhage and CINA-LVO for large vessel occlusion, seamlessly integrate into existing radiology workflows to prioritize urgent cases. By automating repetitive tasks and providing a second set of eyes, Avicenna.AI reduces interpretation time, optimizes patient management, and enhances overall radiology workflow efficiency. The AI algorithms are validated on diverse datasets and scanner models, ensuring high accuracy and generalizability across different clinical settings.
The primary target audience includes radiologists, emergency physicians, and healthcare providers who require rapid and accurate detection of critical conditions in CT scans to improve patient outcomes and optimize radiology workflows.